AREV Life Sciences Global Corp.（AREVF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · AREVF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12	2018-12
Revenue
Revenue	$0.05M	$0.25M	$0.19M	$0.19M	$0.00M
Cost of Revenue	$0.02M	$0.07M	$0.00M	$0.07M	$0.05M
Gross Profit	$0.03M	$0.19M	$0.19M	$0.13M	($0.05M)
Gross Margin %(computed)	59.33%	72.60%	100.00%	66.33%	—
Operating Expenses
R&D Expenses	$0.08M	$0.15M	$0.13M	$1.15M	$0.20M
G&A Expenses	$0.99M	$1.44M	$0.56M	$1.96M	$1.53M
Total Operating Expenses	$1.29M	$1.68M	$0.64M	$3.22M	$1.69M
Operating Income	($1.39M)	($1.50M)	($0.45M)	($3.03M)	($1.69M)
Operating Margin %(computed)	—	-587.00%	-237.34%	—	—
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.01M	$0.05M	$0.06M	$0.07M	$0.04M
Income Before Tax	($1.44M)	($0.99M)	($1.05M)	($3.19M)	($8.43M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.04M
Net Income	($1.44M)	($0.99M)	($1.05M)	($3.19M)	($8.43M)
Net Margin %(computed)	—	-388.36%	-550.37%	—	—
Per Share & EBITDA
EPS (Basic)	$-0.05	$-0.04	$-0.07	$-0.36	$-1.47
Wtd Avg Shares	30.07M	27.47M	15.36M	8.96M	5.73M
EBITDA	($1.31M)	($0.80M)	($0.50M)	($3.05M)	($1.64M)
EBITDA Margin %(computed)	—	-312.80%	-262.26%	—	—